Reduced in vitro production of interferon-gamma, interleukin-4 and interleukin-12 and increased production of interleukin-6, interleukin-10 and tumour necrosis factor-alpha in systemic lupus erythematosus.: Weak correlations of cytokine production with disease activity

被引:34
作者
Jones, BM [1 ]
Liu, TF [1 ]
Wong, RWS [1 ]
机构
[1] Univ Hong Kong, Queen Mary Hosp, Dept Pathol, Div Immunol, Hong Kong, Hong Kong, Peoples R China
关键词
SLE; cytokines; disease activity; ELISPOT;
D O I
10.3109/08916939908994055
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Production of cytokines in unstimulated and mitogen-stimulated cultures were evaluated by ELISPOT in 34 SLE patients with low to moderate disease activity and 23 healthy controls. Significantly reduced production of IFN gamma, IL4 and IL12 and significantly increased production of IL6, IL10 and TNF alpha were found in patients with SLE, Regression analysis revealed that production of all six cytokines tended to decrease with increasing disease activity, but negative correlation with SLEDAI was significant (p < 0.05) only for PHA-stimulated IL4, unstimulated and PHA-stimulated IL10 and SAG-stimulated IL6, Negative correlation of stimulated and unstimulated IL6 and TNF alpha production with anti-DNA antibody levels were also significant.
引用
收藏
页码:117 / 124
页数:8
相关论文
共 31 条
[1]   Immunoregulatory circuits and potential treatment of connective tissue diseases [J].
AlcocerVarela, J ;
Llorente, L ;
AlarconSegovia, D .
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1996, 111 (04) :348-354
[2]   CYTOKINE PROFILE IN SYSTEMIC LUPUS-ERYTHEMATOSUS, RHEUMATOID-ARTHRITIS, AND OTHER RHEUMATIC DISEASES [J].
ALJANADI, M ;
ALBALLA, S ;
ALDALAAN, A ;
RAZIUDDIN, S .
JOURNAL OF CLINICAL IMMUNOLOGY, 1993, 13 (01) :58-67
[3]   Immune complexes are potent inhibitors of interleukin-12 secretion by human monocytes [J].
Berger, S ;
Chandra, R ;
Ballo, H ;
Hildenbrand, R ;
Stutte, HJ .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (11) :2994-3000
[4]   DERIVATION OF THE SLEDAI - A DISEASE-ACTIVITY INDEX FOR LUPUS PATIENTS [J].
BOMBARDIER, C ;
GLADMAN, DD ;
UROWITZ, MB ;
CARON, D ;
CHANG, CH .
ARTHRITIS AND RHEUMATISM, 1992, 35 (06) :630-640
[5]  
CUADRADO MJ, 1993, LUPUS, V2, P257
[6]   A SOLID-PHASE ENZYME-LINKED IMMUNOSPOT (ELISPOT) ASSAY FOR ENUMERATION OF SPECIFIC ANTIBODY-SECRETING CELLS [J].
CZERKINSKY, CC ;
NILSSON, LA ;
NYGREN, H ;
OUCHTERLONY, O ;
TARKOWSKI, A .
JOURNAL OF IMMUNOLOGICAL METHODS, 1983, 65 (1-2) :109-121
[7]   PRODUCTION OF NATURAL-KILLER-CELL STIMULATORY FACTOR (INTERLEUKIN-12) BY PERIPHERAL-BLOOD MONONUCLEAR-CELLS [J].
DANDREA, A ;
RENGARAJU, M ;
VALIANTE, NM ;
CHEHIMI, J ;
KUBIN, M ;
ASTE, M ;
CHAN, SH ;
KOBAYASHI, M ;
YOUNG, D ;
NICKBARG, E ;
CHIZZONITE, R ;
WOLF, SF ;
TRINCHIERI, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (05) :1387-1398
[8]   Disease severity in patients with systemic lupus erythematosus correlates with an increased ratio of interleukin-10:Interferon-gamma-secreting cells in the peripheral blood [J].
Hagiwara, E ;
Gourley, MF ;
Lee, S ;
Klinman, DM .
ARTHRITIS AND RHEUMATISM, 1996, 39 (03) :379-385
[9]   SERUM INTERLEUKIN-10 TITERS IN SYSTEMIC LUPUS-ERYTHEMATOSUS REFLECT DISEASE-ACTIVITY [J].
HOUSSIAU, FA ;
LEFEBVRE, C ;
VANDENBERGHE, M ;
LAMBERT, M ;
DEVOGELAER, JP ;
RENAULD, JC .
LUPUS, 1995, 4 (05) :393-395
[10]   DISEASE-ACTIVITY IN SYSTEMIC LUPUS-ERYTHEMATOSUS RELATED TO A RANGE OF ANTIBODIES BINDING DNA AND SYNTHETIC POLYNUCLEOTIDES [J].
ISENBERG, DA ;
DUDENEY, C ;
WILLIAMS, W ;
TODDPOKROPEK, A ;
STOLLAR, BD .
ANNALS OF THE RHEUMATIC DISEASES, 1988, 47 (09) :717-724